US patent office grants Charpentier CRISPR patent
ERS Genomics Ltd, which was formed to provide broad access to the CRISPR/Cas9 intellectual property co-owned by Dr. Emmanuelle Charpentier, announced...
EU ministers set to exclude CRISPR crops from GMO legislation
Following a proposal from the Netherlands supported by Estonia, Denmark and Belgium, presented in Brussels, EU agriculture ministers seem decided to...
Drug puts CAR T activity on hold
CAR T cells are invaluable as a last line defense for patients suffering from blood cancers. However, they can cause highly severe side effects such...
Hedging success
Setting the tone: successful entrepreneur Jean-Paul Clozel (Idorsia, formerly Actelion) warned of taking upcoming threats like populism too lightly....
Breakthrough in liquid biopsy
Scientists from Germany and the US have created a laser-based platform that can quickly and noninvasively screen large quantities of blood in...
Most expensive gene therapy globally approved
Most patients with the inheritable genetic defect in the SMN1 (survival motor neuron 1) gene, leading to progressive muscle weakness and paralysis,...
Dutch-Italian team improves retinal gene therapy
Retinal gene therapy with adeno-associated viral (AAV) vectors holds promises for treating inherited and noninherited diseases of the eye. Though...